Medication-related osteonecrosis of the jaw (MRONJ) is an uncommon pathology, but it has important consequences for the patient’s quality of life. It is essential to identify the different drugs related to this pathology in order to prevent it. In this webinar we will review some key points about the etiology, prevention and treatment of the MRONJ.

Dr. Eduardo Anitua

Surgeon and BTI Scientific Director, Vitoria-Gasteiz – Spain

Degree in Medicine and Surgery from the University of Salamanca. PhD in Medicine and Surgery from the University of Valencia. Specialised in Stomatology from the University of the Basque Country. Honorary Degree at the University of Buenos Aires (UBA).